statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HIV Medicine Maker Theratechnologies 'Wraps Up Strong Second Quarter,' Stock Soars

Theratechnologies reports Q2 2024 sales of $22.02 million, a 25.5% YoY increase, driven by strong demand for EGRIFTA SV. Net income reached $1 million with an adjusted EBITDA of $5.5 million. The...

Theratechnologies Appoints Elina Tea to its Board of Directors

MONTREAL, April 05, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ( Theratechnologies or the Company ) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update

MONTREAL, April 03, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ( Theratechnologies or the Company ) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Theratechnologies Inc. (NASDAQ:THTX) Short Interest Down 35.7% in March

Theratechnologies Inc. (NASDAQ:THTX - Get Free Report) was the recipient of a large drop in short interest in March. As of March 15th, there was short interest totalling 17,100 shares, a drop of...

Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology  Platform

Study to assess new camptothecin-peptide conjugates for the treatment of sortilin-positive colorectal cancers Separate data to highlight activity of sudocetaxel zendusortide (TH1902) to trigger the...

Theratechnologies Appoints Jordan Zwick to its Board of Directors

MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ( Theratechnologies or the Company ) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Theratechnologies Welcomes New Board Member

Theratechnologies (TSE:TH) has released an update. Theratechnologies Inc., a biopharmaceutical company, has announced the appointment of Jordan Zwi...

Theratechnologies Announces Update on its Preclinical Oncology Research Program

Company continues to shift to commercial focus as it seeks partners to advance R&D MONTREAL, March 22, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ( Theratechnologies or the Company ) (TSX...

Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

Medical Review Committee approved initiation of recruitment of next cohort of patients, in alignment with dose optimization protocol First patient out of six already enrolled and treated with...

Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau

MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ( Theratechnologies or the Company ) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.

Volume	53,575.00
52-Wk High	$3.29
52-Wk Low	$0.88

THTX Theratechnologies Inc.

About

Feed

News

Earnings

Fundamentals